Expand Your Network at One of Biocom’s 150+ Annual Events
When:
Wed Feb 28 15:30:00 GMT 2018 - Fri Mar 02 01:30:00 GMT 2018
Where:
The Lodge at Torrey Pines
11480 N Torrey Pines Rd
La Jolla, 92037
CONFERENCE IS SOLD OUT: TO BE ADDED TO THE WAITLIST PLEASE EMAIL ANGELA WIESZCHOWKSKI AT ANGELAW@BIOCOM.ORG
Biocom's 8th Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us in San Diego on February 28th and March 1st, 2018, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers.
DOWNLOAD CONFERENCE AGENDA
New to 2018: BIO’s One-on-One Partnering System:
We heard your concerns and feedback from 2017 and have changed our partnering system platform for our 2018 conference. The Global Life Science Partnering Conference now utilizes BIO’s One-on-One Partnering System. Additionally, after exceeding our meeting space in 2017, we are excited to announce that we have added additional meeting locations and tables for one-on-one meetings in 2018. Participating in one-on-one partnering at the Biocom Global Life Science Partnering Conference is a unique and valuable experience that allows you to meet one-on-one in a private setting with attendees of your choice throughout the length of the entire conference. The partnering system will open the week of January 15th, 2018.
Attendee Benefits:
300+ Attendees
350+ One-on-One Partnering Meetings
6 Panel Discussions with Industry Thought Leaders from Around the Globe
1 Fireside Chat from Industry Luminaries
1 Keynote Presentation
Access to Emerging Companies Seeking Funding and Partnerships
Gala Networking Reception Situated Atop La Jolla’s Coastline & Torrey Pines Golf Course
Meet Our Conference Speakers:
Jerel Banks, Chief Investment Officer, NantVentures
Paul Biondi, SVP, Head of Business Development, Bristol-Myers Squibb
Kathy Bowdish, Vice President Global R&D and Head of Sunrise Ventures, Sanofi U.S.
Paola Casarosa, Corporate Vice President Licensing, Boehringer Ingelheim
Hannah Chang, Investment Director, Wu Capital
Jon Edwards, Principal, Medicxi
Daniel Estes, Ph.D., Partner, Frazier Healthcare Partners
Chris Haskell, Vice President and Head, West Coast Innovation Center, Bayer
Daria Hazuda, Vice President of Infectious Diseases Discovery, Merck Research Laboratories
Natasha Hernday, Senior VP Corporate Development, Seattle Genetics
John Hood, Founder & CEO, Impact Biomedicines
David Kabakoff, Executive Partner, Private Equity, Sofinnova Ventures
Balraj Kakkar, Partner and Managing Director, Ernst & Young LLP
Kim Kamdar, Partner, Domain Associates
Syed Kazmi, Executive Director, Business Development, Amgen
Chau Khuong, Private Equity Partner, Orbimed
Tomas Landh, Innovation Sourcing Vice President, Senior Principal Scientist R&D External Innovation Sourcing, Novo Nordisk A/S Denmark
Ji Li, Executive Vice President, Global Head of Business Development, BeiGene
Bill Mendez, Vice President Alliance Management, BD Strategy & Operations, Pharma R&D, GSK
David Moller, Chief Scientific Officer, Sigilon Therapeutics
Ron Newbold, Senior Vice President and Head of US Business Development & Alliance Management, Otsuka America Pharmaceuticals
Oleg Nodelman, Founder and Managing Director, EcoR1
Carole Nuechterlein, Head, Roche Venture Fund
Michael O’Donnell, Partner, Morrison Foerster
Catherine Oyler, Global Head, Strategy & Operations, Johnson & Johnson External Innovation
Camille Samuels, Partner, Venrock
Andy Schwab, Founder and Managing Partner, 5AM Ventures
Armen Shanafelt, Ph.D., General Partner, Lilly Ventures
Jason Skolnik, Corporate and Securities Partner, Wilson Sonsini Goodrick & Rosati
Bob Smith, Senior Vice President, Global Gene Therapy Business, Rare Disease, Global Innovation Pharma, Pfizer Inc.
Avi Spier, Director, NIBR BD&L, Search and Evaluation, Novartis
Kumar Srinivasan, Vice President, Head of Scientific Partnering & Alliances, AstraZeneca
Darryl Steensma, Counsel, Latham & Watkins
Bruce Steel, Managing Director, BioMed Ventures
Ben Thorner, Senior Vice President and Head of Business Development & Licensing, Merck Ventures
DA Wallach, Recording Artist and Songwriter Turned Investor
Jeff Warmke, Senior Vice President, External Scientific Affairs, Daiichi Sankyo
DOWNLOAD CONFERENCE AGENDA
Company Presenters Announced
We had an overwhelming amount of interest to present during the company presentations for 2018! Congratulations to the following 25 companies that were selected to present:
3E Therapeutics
Abreos Biosciences
Amarantus BioScience
BioEclipse Therpaeutics, Inc.
Biological Dynamics
Coyne Scientific, LLC
CureMatch
Denovo Biopharma
Fulcrum Therapeutics
Hamamtsu University School of Medicine
Histogen
Leading BioSciences
MatriSys Bioscience
MDI Therapeutics, Inc.
Metacrine
Oncolytics Biotech, Inc.
Rapid Novor
Roswell Biotechnologies
Sanguine Biosciences
Sirius Japan
Sorrento Therapeutics
Synbal, Inc.
TREK Therapeutics
Viracta Therapeutics
XOMA Corporation
Biocom Industry Member: Employee Head Count <10 Today's Price: 895.0 |
|
Biocom Industry Member:Employee Head Count 10-100 Today's Price: 1795.0 |
|
Biocom Industry Member: Employee Head Count >100 Today's Price: 2695.0 |
|
Biocom Member: General/Service Provider Today's Price: 2970.0 |
|
Non-Member: Industry: Employee Head Count <10 Today's Price: 995.0 |
|
Non-Member: Industry: Employee Head Count 10-100 Today's Price: 1995.0 |
|
Non-Member: Industry: Employee Head Count >100 Today's Price: 2995.0 |
|
Non-Member: General/Service Provider Today's Price: 3300.0 |
|